These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15335396

  • 21. Renal failure in patients with cirrhosis.
    Mackelaite L, Alsauskas ZC, Ranganna K.
    Med Clin North Am; 2009 Jul; 93(4):855-69, viii. PubMed ID: 19577118
    [Abstract] [Full Text] [Related]

  • 22. Recent advances in hepatorenal syndrome.
    Arroyo V, Torre A, Guevara M.
    Trop Gastroenterol; 2005 Jul; 26(1):13-20. PubMed ID: 15974232
    [Abstract] [Full Text] [Related]

  • 23. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [Abstract] [Full Text] [Related]

  • 24. Hepatorenal syndrome in the intensive care unit.
    Wadei HM, Gonwa TA.
    J Intensive Care Med; 2013 Sep; 28(2):79-92. PubMed ID: 21859679
    [Abstract] [Full Text] [Related]

  • 25. [Hepatorenal syndrome].
    Mancini E.
    G Ital Nefrol; 2012 Sep; 29(5):563-78. PubMed ID: 23117737
    [Abstract] [Full Text] [Related]

  • 26. Diagnosis and treatment of acute renal failure in patients with cirrhosis.
    Moreau R, Lebrec D.
    Best Pract Res Clin Gastroenterol; 2007 Sep; 21(1):111-23. PubMed ID: 17223500
    [Abstract] [Full Text] [Related]

  • 27. Hepatorenal syndrome: new perspectives in pathophysiology and management.
    Kes P.
    Acta Med Croatica; 2000 Sep; 54(4-5):165-73. PubMed ID: 11379481
    [Abstract] [Full Text] [Related]

  • 28. Hepatorenal syndrome.
    Gattoni A, Marotta F, Vangieri B, Pisani G, Cristiano F.
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [Abstract] [Full Text] [Related]

  • 29. Frequency of hepatorenal syndrome among cirrhotics.
    Kumar R, Ahmed R, Rathi SK, Sethar GH.
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):590-3. PubMed ID: 19810292
    [Abstract] [Full Text] [Related]

  • 30. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
    Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR.
    J Hepatol; 2019 Oct; 71(4):811-822. PubMed ID: 31302175
    [Abstract] [Full Text] [Related]

  • 31. Review article: pharmacological treatment of hepatorenal syndrome.
    Ginès P, Torre A, Terra C, Guevara M.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
    [Abstract] [Full Text] [Related]

  • 32. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).
    Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, McKenna GJ, Randall HB, Sanchez EQ, Klintmalm GB.
    Liver Transpl; 2007 Jun; 13(6):838-43. PubMed ID: 17539003
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome.
    Testro AG, Wongseelashote S, Angus PW, Gow PJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1535-40. PubMed ID: 17784863
    [Abstract] [Full Text] [Related]

  • 34. [Diagnosis and therapy of hepatorenal syndrome].
    Stremmel W, Strohmeyer G.
    Schweiz Rundsch Med Prax; 1992 Jun 09; 81(24):806-8. PubMed ID: 1376484
    [Abstract] [Full Text] [Related]

  • 35. Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis.
    Schrier RW, Shchekochikhin D, Ginès P.
    Nephrol Dial Transplant; 2012 Jul 09; 27(7):2625-8. PubMed ID: 22492830
    [No Abstract] [Full Text] [Related]

  • 36. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
    Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V.
    Postgrad Med J; 2008 Dec 09; 84(998):662-70. PubMed ID: 19201943
    [Abstract] [Full Text] [Related]

  • 37. Review article: prognosis of hepatorenal syndrome--has it changed with current practice?
    Angeli P.
    Aliment Pharmacol Ther; 2004 Sep 09; 20 Suppl 3():44-6; discussion 47-8. PubMed ID: 15335400
    [Abstract] [Full Text] [Related]

  • 38. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.
    Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T.
    Liver Int; 2006 Sep 09; 26(7):834-9. PubMed ID: 16911466
    [Abstract] [Full Text] [Related]

  • 39. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.
    Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V.
    Gut; 2011 May 09; 60(5):702-9. PubMed ID: 21325171
    [Abstract] [Full Text] [Related]

  • 40. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A, Ginès P.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun 09; 3(6):338-48. PubMed ID: 16741553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.